Bear Study Breaks Down

Authors retract a paper on grizzlies’ metabolism after finding one person made up data.

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

PIXABAY, WERNER22BRIGITTEA scientist working for Amgen faked data in a study on how grizzly bears avoid developing long-term metabolic problems, despite gaining weight and ceasing activity during hibernation. Upon learning of the misconduct, the authors, including several based at the University of Idaho and Washington State University (WSU), this week (September 1) retracted their 2014 Cell Metabolism study.

“We know data were actually manipulated, and that just cannot stand,” Amgen’s research chief Alexander Kamb told The Wall Street Journal.

The offending author has not been named. The Wall Street Journal pointed out that one of the authors, Kevin Corbit of Amgen, was fired for data manipulation. But Corbit said his dismissal was tied to a separate incident, and that he stands by the grizzly bear study findings, which showed insulin sensitivity reversed course during the year. In the fall, insulin signaling remained intact and bears gained weight. Then, during hibernation, bears became insulin resistant. By the spring, their insulin sensitivity returned to normal. “The results were so different from what we see in humans and rodents that we were all very skeptical at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies